Full-Time
Associate Director
Digital Centric Marketing
Posted on 2/27/2024
Develops therapies for CNS conditions
Senior
New York, NY, USA
- BA or BS; MBA or other advanced degree preferred
- Minimum 5-7 years of experience in pharmaceutical/biotechnology marketing
- Strong digital marketing aptitude and experience
- Ability to work on site Monday, Tuesday, and Thursday
- Experience in Generative AI / Business AI
- CNS disease experience and/or launch experience
- Proven ability to run multiple tasks concurrently under aggressive timelines in a dynamic environment, comfortable with uncertainty and high expectations
- Strong project and process management skills, including competency in agency management and budget management
- Strong interpersonal and presentation skills
- Drive the development and implementation of integrated, multi-channel Healthcare Professional (HCP) campaign strategies and tactics
- Implement non-personal, omnichannel strategies to engage healthcare professionals and optimize campaign effectiveness using AI-driven insights
- Lead the development and implementation of digital field tools and resources designed to extend reach, frequency, and impact to HCPs
- Identify appropriate measurements and ROI, and develop comprehensive reporting to evaluate the effectiveness of marketing campaigns
- Lead reviews of promotional materials with Regulatory/Legal/Medical
- Collaborate effectively with sales and marketing, market access, patient support, market research, medical affairs, commercial operations, data and analytics, finance, and other cross-functional partners
Axsome Therapeutics is dedicated to the development of groundbreaking therapies for central nervous system conditions, focusing on addressing the often underserved needs in depression, Alzheimer's disease, and other related disorders. With its commitment to unique mechanisms of action, this company provides a compelling work environment for those passionate about making a significant impact in healthcare. Employees at Axsome engage in pioneering work, driving the advancement of new treatments that promise to enhance patient lives significantly.
Company Stage
IPO
Total Funding
$430.7M
Headquarters
New York, New York
Founded
2012